NDs-IN-1

Overview

(Neurodegenerative diseases) NDs-IN-1 (Compound 3g) inhibits the activities of key enzymes such as hBACE-1 , hAChE and hMAO-B . NDs-IN-1 is a novel non-covalent multi-target inhibitor. NDs-IN-1 is mainly used in the study of neurodegenerative diseases.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Monoamine Oxidase | Products > Signaling Pathways > NO Synthase | Products > Signaling Pathways > PARP | Products > Signaling Pathways > p38 MAPK | Products > Signaling Pathways > RIP kinase | Products > Signaling Pathways > Phospholipase | Products > Signaling Pathways > Indoleamine 2,3-Dioxygenase (IDO) | Products > Signaling Pathways > Dihydroorotate Dehydrogenase | Products > Signaling Pathways > Cholinesterase (ChE)

Product Information

• Catalog No.: HY-158334
• CAS No.: 3033806-97-9
• Molecular Formula: C20H18N2O2
• Molecular Weight: 318.37
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source